Group 1 - Upslope Capital Management aims to provide attractive, equity-like returns while reducing market risk and maintaining low correlation with traditional equity strategies [1] - The Fund delivered a return of +2.0% (net) in Q4 2025, outperforming the S&P Midcap 400 ETF and HFRX Equity Hedge Index, which returned +1.6% [1] - For the full year 2025, the Fund achieved a return of +14.8%, significantly higher than the +7.2% and +10.1% returns of the respective indexes [1] Group 2 - Henry Schein, Inc. (NASDAQ:HSIC) has been added to Upslope's portfolio, with a recent stock price of $79.98 per share as of January 16, 2026 [2] - The one-month return for Henry Schein, Inc. was 3.09%, and its shares increased by 9.23% over the last 52 weeks [2] - Henry Schein, Inc. is the leading distributor of dental products in the U.S. and holds a significant market share in various countries, with 52% of Dental sales from the U.S. [3]
Mixed Strategic Drivers Led Upslope Capital Management to Pick Henry Schein (HSIC)